Overview

Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users

Status:
Recruiting

Trial end date:
2024-08-30

Target enrollment:
0

Participant gender:
Female

Summary

Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. This clinical trial use to provide drug to stop abnormal uterine bleeding from DMPA

Phase:

N/A

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

Rajavithi Hospital

Treatments:

Estradiol
Tranexamic Acid

Criteria

Inclusion Criteria:

- Abnormal uterine bleeding more than 7 days after first DMPA injection

- Provide inform consent with patient

- Can understand thai language

Exclusion Criteria:

- Have contraindication to use Tranexamic acid and estrogen such as hypertension,
Stroke, MI, DM, Renal disease, Liver disease, CA breast etc.

- Have pathology in uterus from pelvic examination, pap smear and ultrasound

- Current pelvic infection

- Postpartum less than 6 months

- History deep vein thrombosis

- Breastfeeding